Venture Life Group PLC
LSE:VLG

Watchlist Manager
Venture Life Group PLC Logo
Venture Life Group PLC
LSE:VLG
Watchlist
Price: 38 GBX 1.33% Market Closed
Market Cap: 48.3m GBX
Have any thoughts about
Venture Life Group PLC?
Write Note

Venture Life Group PLC
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Venture Life Group PLC
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Venture Life Group PLC
LSE:VLG
Other Receivables
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Unilever PLC
LSE:ULVR
Other Receivables
€1.7B
CAGR 3-Years
83%
CAGR 5-Years
44%
CAGR 10-Years
20%
PZ Cussons PLC
LSE:PZC
Other Receivables
ÂŁ200k
CAGR 3-Years
-76%
CAGR 5-Years
-38%
CAGR 10-Years
-41%
Science in Sport PLC
LSE:SIS
Other Receivables
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Warpaint London PLC
LSE:W7L
Other Receivables
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HALEON PLC
LSE:HLN
Other Receivables
ÂŁ488m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Venture Life Group PLC
Glance View

Market Cap
48.1m GBX
Industry
Consumer products

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

VLG Intrinsic Value
66.69 GBX
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Venture Life Group PLC's Other Receivables?
Other Receivables
0 GBP

Based on the financial report for Jun 30, 2024, Venture Life Group PLC's Other Receivables amounts to 0 GBP.

Back to Top